Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

2008 Results

Unlock all the news: Be the first to know and act before the market!
100% Free Registration
ITEQ : 2024 Meeting Minutes
PU
ASCO 2024: Efficacy and safety of the vebreltinib in previously treated, IDH mutant high grade glioma patients with PTPRZ1 MET FUsion GENe (FUGEN): a randomized, multicentre, open label, phase II/III trial
PU
Apollomics Announces Vebreltinib Data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
GL
Jochu Technology Co., Ltd. Announces Remuneration Committee Changes
CI
Tai Tung Communication Co., Ltd. Announces Audit Committee Changes
CI
Shandong Xinhua Pharmaceutical Company Limited Receives Notice of Approval of Supplementary Drug Application from the National Medical Products Administration
CI
GEM Services, Inc. Announces Directorate Changes
CI
Jochu Technology Co., Ltd. Announces the Dismissal of Members of the Remuneration Committee
CI
Asia Electronic Material Co., Ltd. Announces Board Changes
CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Board Appointments
CI
Certain A Shares of Shandong Yuma Sun-shading Technology Corp., Ltd. are subject to a Lock-Up Agreement Ending on 17-MAY-2024.
CI
EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for Presentations at 2024 European Hematology Association Hybrid Congress
PR
Ouhua Energy Holdings Limited Announces Reconstitution of Board Committees
CI
Roo Hsing Co., Ltd agreed to acquire remaining 49% stake in 3Y Universal Company Limited from Century Eagle International Limited for $5 million.
CI
Wave Life Sciences : Chemical Design of Oligonucleotides That Support Targeted RNA Editing in the CNS of Non-Human Primates
PU
Apollomics Announces Private Placement Financing and Addition to Board of Directors
GL
Taiwan Cement Corp. Announces Management Changes
CI
Certain A Shares of LAY-OUT Planning Consultants Co. Ltd. are subject to a Lock-Up Agreement Ending on 7-MAY-2024.
CI
Union Insurance Co., Ltd. Announces Appointments to Sustainable Committee
CI
Avistone Biotechnology Co. Ltd. Receives Approval from the National Medical Products Administration of China for Vebrelinib (APL-101) for the Treatment of Gliomas with Met Fusion Gene
CI
Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene
GL
Certain A Shares of Shanghai Urban Architecture Design Co., Ltd. are subject to a Lock-Up Agreement Ending on 20-APR-2024.
CI
China Vanke says it has plans in place amid short-term liquidity pressure
RE
Apollomics Presents Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting
GL
Jiutian Chemical Group Limited Announces Retirement of Wu Yu Liang as Non-Executive and Lead Independent Director
CI
Property developer China Vanke plans to cut debt, boost cashflow
RE
Transcript : China Vanke Co., Ltd., 2023 Earnings Call, Mar 29, 2024
Apollomics Highlights Clinical Progress and Reports Full Year 2023 Financial Results
GL
Transcript : China Overseas Land & Investment Limited, 2023 Earnings Call, Mar 28, 2024
Certain A Shares of Shaanxi Sirui Advanced Materials Co., Ltd. are subject to a Lock-Up Agreement Ending on 15-MAR-2024.
CI
Apollomics Appoints Matthew Plunkett, Ph.D. as Chief Financial Officer
GL
Jumbo Group Limited Announces Changes to its Board
CI
Shengjing Bank Co., Ltd. Announces Board Changes
CI
Certain A Shares of Zhejiang Chunhui Intelligent Control Co., Ltd. are subject to a Lock-Up Agreement Ending on 10-FEB-2024.
CI
Apollomics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
GL
Certain A Shares of Zhejiang Taitan Co.,Ltd. are subject to a Lock-Up Agreement Ending on 29-JAN-2024.
CI
Apollomics to Participate in a Fireside Chat at the B. Riley Securities’ 2024 Virtual Oncology Conference
GL
Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia
GL
Shenzhen Changfang Group Co., Ltd. Announces Executive Appointments
CI
EHang’s Certified EH216-S Pilotless Passenger-Carrying Aerial Vehicles Debut Commercial Flight Demonstrations in Guangzhou and Hefei
GL
Apollomics Presents Interim Data from Two Ongoing Phase 2 Clinical Trials with Vebreltinib in NSCLC Patients with MetExon14 Skipping Mutation
GL
Yield Go Holdings Ltd. Announces Board Appointments
CI
Apollomics to Participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference
GL
Certain A Shares of Beijing Telesound Electronics Co., Ltd. are subject to a Lock-Up Agreement Ending on 25-NOV-2023.
CI
Apollomics Announces the First Approval of Vebreltinib for MET Exon 14 Skip Non-Small Cell Lung Cancer
GL
NISUN INTERNATIONAL DEVELOPMENT : 21F, 55 LOUSHANGUAN RD CHANGNING DISTRICT, SHANGHAI, 200336 PEOPLE’S REPUBLIC OF CHINA PROXY STATEMENT AND NOTICE OF ANNUAL MEETING OF SHAREHOLDERS FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022 - Form 6-K
PU
Ubiqconn Technology, Inc. Establishes A Sustainable Development Committee
CI
China's Shenzhen state shareholders show liquidity support for Vanke
RE
China's Shenzhen state shareholders show liquidity support for Vanke
RE
Apollomics Announces Report of Activity of Vebreltinib in Glioblastoma Multiforme (GBM) with PTPRZ-MET Fusion
GL
No results for this search
  1. Stock Market
  2. Advanced search
  3. Liang Yu
  4. News